We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
-2.3%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$885M
AUM Growth
+$137M
Cap. Flow
+$160M
Cap. Flow %
18.15%
Top 10 Hldgs %
53.07%
Holding
102
New
30
Increased
15
Reduced
2
Closed
15

Sector Composition

Rank Sector Weight
1 Energy 24.72%
2 Industrials 13.91%
3 Healthcare 9.99%
4 Materials 9.92%
5 Communication Services 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$416M
$2.11M 0.24%
148,054
+47,277
+47% +$1.26M
SRRA
52
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.07M 0.23%
92,215
BMTX
53
DELISTED
BM Technologies, Inc.
BMTX
$2.01M 0.23%
200,000
GIX.U
54
DELISTED
GigCapital2, Inc.
GIX.U
$2.01M 0.23%
+200,172
New +$2.01M
LOTZ
55
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$1.95M 0.22%
+200,400
New +$1.95M
RIDE
56
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$1.94M 0.22%
+13,333
New +$1.95M
GLRE icon
57
Greenlight Captial
GLRE
$563M
$1.91M 0.22%
+224,532
New +$2.31M
LAZR
58
DELISTED
Luminar Technologies
LAZR
$1.51M 0.17%
+10,000
New +$1.49M
MTW icon
59
Manitowoc
MTW
$516M
$1.08M 0.12%
+60,437
New +$1M
HSACU
60
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$1.06M 0.12%
+100,000
New +$1.04M
AVCT
61
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$1.04M 0.12%
6,667
PVT
62
DELISTED
Pivotal Acquisition Corp.
PVT
$1.01M 0.11%
+100,000
New +$1.01M
DEACU
63
DELISTED
Diamond Eagle Acquisition Corp. Unit
DEACU
$1.01M 0.11%
+100,000
New +$1.01M
FTACW
64
DELISTED
FinTech Acquisition Corp. III Warrant
FTACW
$348K 0.04%
250,000
GRAF.WS
65
DELISTED
Graf Industrial Corp. Warrants (each exercisable for three-quarters of one share of common stock, ea
GRAF.WS
$335K 0.04%
850,000
CFFAW
66
DELISTED
CF Finance Acquisition Corp. Warrant
CFFAW
$315K 0.04%
525,000
SPAQ.WS
67
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
$267K 0.03%
300,000
EMWP
68
DELISTED
Eros Media World PLC
EMWP
$216K 0.02%
+7,988
New +$1.08M
CTACW
69
DELISTED
ChaSerg Technology Acquisition Corp. Warrant
CTACW
$206K 0.02%
275,000
ADNWW
70
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$203K 0.02%
700,000
ACTTW
71
DELISTED
Act II Global Acquisition Corp Warrant
ACTTW
$170K 0.02%
+250,000
New +$177K
SAMAW
72
DELISTED
Schultze Special Purpose Acquisition Corp. Warrant
SAMAW
$150K 0.02%
500,000
LCAHW
73
DELISTED
Landcadia Holdings II, Inc. Warrant
LCAHW
$142K 0.02%
+166,666
New +$134K
ASLEW
74
DELISTED
AerSale Corp Warrants
ASLEW
$140K 0.02%
400,000
TRNE.WS
75
DELISTED
Trine Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A
TRNE.WS
$131K 0.01%
+175,000
New +$121K

Similar funds

Mangrove Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Mangrove Partners held 102 positions worth $885M, up 18% from $748M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Mangrove Partners deployed $160M of net new capital in Q2 2019, opening 30 new positions and adding to 15 existing holdings. Its largest new stake was NII Holdings, Inc. Common Stock: 6,776,506 shares worth $11.5M.

By sector, the portfolio is most concentrated in Energy at 25% of assets, down from 34% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an, an estimated $61K trimmed.

  • Mangrove Partners's largest Q2 2019 buy was NII Holdings, Inc. Common Stock: 6,776,506 shares worth $11.5M.
  • Mangrove Partners added most to Green Plains in Q2 2019, an estimated $25.3M increase.
  • Mangrove Partners's biggest Q2 2019 reduction was Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an, cutting an estimated $61K.
  • Mangrove Partners fully exited Stemline Therapeutics, Inc. in Q2 2019, selling an estimated $8.18M.
  • Mangrove Partners's ten largest holdings make up 53% of its $885M portfolio in Q2 2019.
  • Mangrove Partners opened 30 new positions and closed 15 in Q2 2019.
  • Mangrove Partners's portfolio value rose 18% quarter-over-quarter to $885M.

Based on Mangrove Partners's 13F filing for Q2 2019, filed 14 Aug 2019.